Nutrien Ltd vs GeneDx Holdings Corp — how do they compare? Nutrien Ltd trades at $66.8 (market cap $31.67B), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: Nutrien Ltd is far larger — about 17.6× GeneDx Holdings Corp's market cap, and Nutrien Ltd pays a 3.3% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| NTR | WGS | |
|---|---|---|
Market Cap | $31.67B | $1.80B |
Sector | Basic Materials | Technology |
52-Week High | $83.94 | $167.51 |
52-Week Low | $53.64 | $34.51 |
Enterprise Value | $44.84B | $1.80B |
Dividend Yield | 3.3% | — |
Signals from Pluang's Aura AI — not financial advice
Nutrien (NTR) trades at $66.84, down 0.65% with neutral technical signals. The company shows improving fundamentals with Q1 2026 earnings beat and projected revenue growth to $27.8B in 2026. Valuation appears reasonable with P/E of 13.58 and P/S of 1.16. Recent institutional buying activity and a $0.55 dividend payment scheduled for July 2026 provide additional investor appeal.
The outlook remains positive with strong analyst consensus (60.6% buy ratings) and $77.67 price target suggesting 16% upside. Key risks include volatile input costs and fertilizer market dynamics. The combination of reasonable valuation, earnings momentum, and institutional support positions NTR favorably for long-term investors despite near-term market volatility.
No Aura AI signal available yet.
Trailing returns across standard periods
Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients--nitrogen, potash, and phosphate--although its main focus is potash, where it is the global leader in installed capacity with roughly 20% share. The company is also the largest agricultural retailer in the United States, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.
Read more on NTR →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →